Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenge Zhu

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Plos Genetics|July 2, 2015
TopBP1 Governs Hematopoietic Stem/Progenitor Cells Survival in Zebrafish Definitive HematopoiesisLei Gao, Dantong Li, Ke Ma, et al.
Oncogene|September 1, 2018
miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancerJing Sun, Xin Cai, Mingo Mh Yung, et al.
Oncogene|January 16, 2026
Retraction Note: miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancerJing Sun, Xin Cai, Mingo M H Yung, et al.
JCI Insight|December 20, 2019
Secretome profiling identifies neuron-derived neurotrophic factor as a tumor-suppressive factor in lung cancerYa Zhang, Xuefeng Wu, Yan Kai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 10, 2019
ERK Regulates HIF1α-Mediated Platinum Resistance by Directly Targeting PHD2 in Ovarian CancerZhuqing Li, Wei Zhou, Yi Zhang, et al.
Cell Death & Disease|April 2, 2021
SENP1-mediated deSUMOylation of JAK2 regulates its kinase activity and platinum drug resistanceJing Li, Ruiqin Wu, Mingo M H Yung, et al.
Cancer Letters|April 29, 2018
DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancerYunxiao Meng, Chi-Wei Chen, Mingo M H Yung, et al.
Nature Communications|January 27, 2026
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trialTim Kong, Alex Mabry, Maureen Highkin, et al.
Oncogene|April 18, 2018
Autocrine activation of JAK2 by IL-11 promotes platinum drug resistanceWei Zhou, Wei Sun, Mingo M H Yung, et al.
Oncogene|May 11, 2026
Correction to: Autocrine activation of JAK2 by IL-11 promotes platinum drug resistanceWei Zhou, Wei Sun, Mingo M H Yung, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Plos Genetics|July 2, 2015
TopBP1 Governs Hematopoietic Stem/Progenitor Cells Survival in Zebrafish Definitive HematopoiesisLei Gao, Dantong Li, Ke Ma, et al.
Oncogene|September 1, 2018
miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancerJing Sun, Xin Cai, Mingo Mh Yung, et al.
Oncogene|January 16, 2026
Retraction Note: miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancerJing Sun, Xin Cai, Mingo M H Yung, et al.
JCI Insight|December 20, 2019
Secretome profiling identifies neuron-derived neurotrophic factor as a tumor-suppressive factor in lung cancerYa Zhang, Xuefeng Wu, Yan Kai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 10, 2019
ERK Regulates HIF1α-Mediated Platinum Resistance by Directly Targeting PHD2 in Ovarian CancerZhuqing Li, Wei Zhou, Yi Zhang, et al.
Cell Death & Disease|April 2, 2021
SENP1-mediated deSUMOylation of JAK2 regulates its kinase activity and platinum drug resistanceJing Li, Ruiqin Wu, Mingo M H Yung, et al.
Cancer Letters|April 29, 2018
DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancerYunxiao Meng, Chi-Wei Chen, Mingo M H Yung, et al.
Nature Communications|January 27, 2026
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trialTim Kong, Alex Mabry, Maureen Highkin, et al.
Oncogene|April 18, 2018
Autocrine activation of JAK2 by IL-11 promotes platinum drug resistanceWei Zhou, Wei Sun, Mingo M H Yung, et al.
Oncogene|May 11, 2026
Correction to: Autocrine activation of JAK2 by IL-11 promotes platinum drug resistanceWei Zhou, Wei Sun, Mingo M H Yung, et al.
Pageof 6